Jade-1 in cystic renal disease
Jade-1 in cystic renal disease
批准号:
7049325
负责人:
HERBERT TOD COHEN
金额:
$31.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-03-31
关键词:
MDCK cellVon Hippel Lindau syndromeapoptosiscell cyclecell differentiationclinical researchcytogeneticsgenetic regulationgenetically modified animalshuman tissueimmunofluorescence techniquelaboratory mouselaboratory ratpolycystic kidneypolymerase chain reactionprotein structure functionurinary bladder epitheliumwestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of end-stage renal disease. Loss of the polycystin-1 - polycystin-2 interaction is central to disease pathogenesis, but the precise mechanism of cyst formation remains unclear. Intriguingly, disordered renal tubule cell proliferation and apoptosis are consistent features of all the cystic renal diseases. Our laboratory has been closely studying the molecular basis of von HippeI-Lindau (VHL) renal disease, which includes a polycystic kidney phenotype. The similarities between the cystogenic pathways in VHL disease and ADPKD are striking. Jade-1 (gene for Apoptosis and Differentiation in Epithelia) encodes a short-lived, highly-regulated pro-apoptotic transcription factor that is stabilized by the VHL tumor suppressor. Jade-1 resides in prominent nuclear speckles and is most highly expressed in renal tubular epithelial cells. Intriguingly, the pattern of naturally occurring VHL mutations that stabilize Jade-1 suggest a correlation with VHL renal disease risk, which has not been previously described. Jade-1 protein alters the monolayer morphology of renal cells and promotes apoptosis that is blocked by VHL. Jade-1 may help propel a pre-apoptotic epithelial cell off a monolayer, promoting anoikis. Remarkably, wild-type polycystin-1 strongly regulates Jade-1 much like VHL, and this effect is blocked by a disease-causing polycystin-1 mutation in the coiled-coil domain that prevents interaction with polycystin-2. Moreover, Jade-1 is the target of a novel polycystin-1 dominant-negative mechanism. Thus, pro-apoptotic Jade-1 is downstream of both VHL and a common polycystin-1 / polycystin-2 regulatory pathway. Jade-1 may therefore be a central regulator of renal cyst formation in VHL disease and ADPKD, and perhaps in other cystic renal diseases. The Jade-1 - polycystin relationship in cystic disease will be explored through the following Aims:
AIM 1: The mechanism of Jade-1 regulation by polycystin-1
AIM 2:Jade-1 effects on the cell cycle and modulation by polycystin-1
AIM 3: Direct role of Jade-1 in renal cyst formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Jade-1 in cystic renal disease
-
批准号:6861859
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:6768201
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7379930
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7234711
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6686928
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:2733434
-
项目类别:
-
资助金额:$31.63万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:7227198
-
项目类别:
-
资助金额:$30.53万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8585027
-
项目类别:
-
资助金额:$31.06万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8196861
-
项目类别:
-
资助金额:$32.02万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6919315
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:6173732
-
项目类别:
-
资助金额:$29.27万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:7999259
-
项目类别:
-
资助金额:$32.02万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8578133
-
项目类别:
-
资助金额:$6.48万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8787179
-
项目类别:
-
资助金额:$6.69万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:6376964
-
项目类别:
-
资助金额:$33.55万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8527928
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8387038
-
项目类别:
-
资助金额:$30.1万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:7084646
-
项目类别:
-
资助金额:$31.44万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6777002
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:7782104
-
项目类别:
-
资助金额:$33.01万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
海外基金